News
» Go to news mainPublication: MR Imaging of Pediatric Low‑Grade Gliomas: Pretherapeutic Differentiation of BRAF V600E Mutation, BRAF Fusion, and Wild‑Type Tumors in Patients without Neurofibromatosis‑1
Posted by Angie Kinsman on
July 21, 2022
in
Pediatrics
MR Imaging of Pediatric Low-Grade Gliomas: Pretherapeutic Differentiation of BRAFV600E Mutation, BRAFFusion, and Wild-Type Tumors in Patients without Neurofibromatosis-1 A. Trasolini, C. Erker, S. Cheng, C. Crowell, K. McFadden, R. Moineddin, M.A. Sargent and D. Mata-Mbemba. American Journal of Neuroradiology July 2022, DOI: https://doi.org/10.3174/ajnr.A7574
"BACKGROUND AND PURPOSE: The prognosis and treatment of pediatric low-grade gliomas is influenced by their molecular subtype. MR imaging remains the mainstay for initial work-up and surgical planning. We aimed to determine the relationship between imaging patterns and molecular subtypes of pediatric low-grade gliomas." Read more
Recent News
- Just published! Surgical or Endovascular Treatment of MCA Aneurysms: An Agreement Study
- Just published! Endovascular thrombectomy and intravenous alteplase in patients with acute ischemic stroke due to large vessel occlusion: A clinical practice guideline
- Just published! Preparedness of Residents and Medical Students for the Transition to Competence by Design in Diagnostic Radiology Post‑Graduate Medical Education
- Just published! Systematic Review of Diffuse Hemispheric Glioma, H3 G34‑mutant: Outcomes and Associated Clinical Factors
- Just published! Inaugural Pan‑Canadian RADGames: Results From a Successful Approach to Radiology Education for Medical Students
- Just published! Canadian Association of Radiologists Prostate MRI White Paper
- Publication: Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN)
- Publication: MR Imaging of Pediatric Low‑Grade Gliomas: Pretherapeutic Differentiation of BRAF V600E Mutation, BRAF Fusion, and Wild‑Type Tumors in Patients without Neurofibromatosis‑1
Comments
All comments require a name and email address. You may also choose to log-in using your preferred social network or register with Disqus, the software we use for our commenting system. Join the conversation, but keep it clean, stay on the topic and be brief.
Read comments policy.
comments powered by Disqus